Stock Scorecard
Stock Summary for Accelerate Diagnostics Inc (AXDX) - $0.57 as of 5/5/2025 7:33:56 PM EST
Total Score
8 out of 30
Safety Score
13 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AXDX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AXDX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AXDX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AXDX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for AXDX (13 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 1 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AXDX
Financial Details for AXDX
Company Overview |
|
|---|---|
| Ticker | AXDX |
| Company Name | Accelerate Diagnostics Inc |
| Country | USA |
| Description | Accelerate Diagnostics, Inc., an in vitro diagnostic company, offers solutions for diagnosing serious infections in the United States, Europe, and the Middle East. The company is headquartered in Tucson, Arizona. |
| Sector Name | LIFE SCIENCES |
| Industry Name | LABORATORY ANALYTICAL INSTRUMENTS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 5/6/2025 |
Stock Price History |
|
| Last Day Price | 0.57 |
| Price 4 Years Ago | 52.20 |
| Last Day Price Updated | 5/5/2025 7:33:56 PM EST |
| Last Day Volume | 14,279 |
| Average Daily Volume | 54,300 |
| 52-Week High | 2.09 |
| 52-Week Low | 0.49 |
| Last Price to 52 Week Low | 16.33% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 30.80 |
| Sector PE | 37.03 |
| 5-Year Average PE | -10.54 |
| Free Cash Flow Ratio | 0.95 |
| Industry Free Cash Flow Ratio | 123.71 |
| Sector Free Cash Flow Ratio | 29.42 |
| Current Ratio Most Recent Quarter | 0.71 |
| Total Cash Per Share | 0.60 |
| Book Value Per Share Most Recent Quarter | -2.22 |
| Price to Book Ratio | 0.00 |
| Industry Price to Book Ratio | 999.29 |
| Sector Price to Book Ratio | 21.93 |
| Price to Sales Ratio Twelve Trailing Months | 1.12 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.92 |
| Sector Price to Sales Ratio Twelve Trailing Months | 28.34 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 25,210,400 |
| Market Capitalization | 14,369,928 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.64% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 18.78% |
| Reported EPS 12 Trailing Months | -2.15 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -2.37 |
| Net Income Twelve Trailing Months | -45,405,000 |
| Net Income Past Year | -50,045,000 |
| Net Income Prior Year | -61,618,000 |
| Quarterly Revenue Growth YOY | -7.00% |
| 5-Year Revenue Growth | 4.70% |
| Operating Margin Twelve Trailing Months | -281.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 15,098,000 |
| Total Cash Past Year | 15,098,000 |
| Total Cash Prior Year | 12,138,000 |
| Net Cash Position Most Recent Quarter | -31,741,000 |
| Net Cash Position Past Year | -31,741,000 |
| Long Term Debt Past Year | 46,839,000 |
| Long Term Debt Prior Year | 36,102,000 |
| Total Debt Most Recent Quarter | 46,839,000 |
| Equity to Debt Ratio Past Year | 0.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.00 |
| Total Stockholder Equity Past Year | -56,040,000 |
| Total Stockholder Equity Prior Year | -19,888,000 |
| Total Stockholder Equity Most Recent Quarter | -56,040,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -20,818,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.83 |
| Free Cash Flow Past Year | -24,703,000 |
| Free Cash Flow Prior Year | -41,230,999 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.09 |
| MACD Signal | -0.11 |
| 20-Day Bollinger Lower Band | 0.44 |
| 20-Day Bollinger Middle Band | 1.00 |
| 20-Day Bollinger Upper Band | 1.56 |
| Beta | 0.46 |
| RSI | 34.34 |
| 50-Day SMA | 1.34 |
| 150-Day SMA | 5.35 |
| 200-Day SMA | 14.41 |
System |
|
| Modified | 5/5/2025 6:17:54 PM EST |